Secret Allergan Meeting Points To Aggressive Takeover StrategyMark Melin
Allergan is building an acquisition machine the likes of which institutional investors and hedge funds may not yet comprehend. The company and its bold ambitions to become the dominant category leader were benchmarked in a recent secret meeting that revealed how a prototype for a next-generation acquisition model is being built. Once the firm achieves category dominance they achieve pricing power while having greater flexibility to reduce operating expenses, a corporate tactic that hedge fund managers tend to applaud, as is the case . . .
This content is exclusively for paying members.
If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.